Boehringer Ingelheim’s Uli Broedl, senior vice president and head of global clinical development and operations, discusses the company’s One Medicine Platform, partnership with Veeva, and how a platform approach aligns with their guiding principle to transform patients’ lives for generations.
Download File Here (PDF, 460KB)
Learn more about Boehringer Ingelheim’s partnership with Veeva or read in ACRP how they are unifying clinical to improve patient outcomes.